Jämför metoder
Granska de valda metoderna sida vid sida; rader som skiljer sig är markerade.
| Populationsfarmakodynamisk modellering× | Michaelis-Mentens kinetik× | |
|---|---|---|
| Ämnesområde | Farmakologi | Farmakologi |
| Familj | Process / pipeline | Process / pipeline |
| Ursprungsår≠ | 1992 | 1913 |
| Upphovsperson≠ | Lewis Sheiner and Stephen Roush | Leonor Michaelis and Maud Menten |
| Typ≠ | dose-response modeling | mechanistic model |
| Ursprungskälla≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ |
| Alias | PopPD, population PD, hierarchical PD modeling | MM kinetics, Michaelis constant, Vmax |
| Närliggande≠ | 3 | 2 |
| Sammanfattning≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. |
| ScholarGateDatamängd ↗ |
|
|